- Trajenta® Summary of Product Characteristics Available at: http://www.medicines.org.uk/emc/medicine/25000/SPC/Trajenta+5+mg+film-coated+tablets/ (accessed June 2013)
- Barnett AH et al. Diabetes Obes Metab 2012;14(12):1145-1154
- Taskinen M-R et al. Diabetes Obes Metab 2011; 13:64-74
- Owens DR, et al. Diabet Med 2011;28:1352-1361
- Yki-Jarvinen H et al. Poster No. 999-p. The 72nd Scientific Sessions of the American Diabetes Association, 8-12 June 2012, Philadelphia, PA, USA
- Gallwitz B et al. Lancet 2012;380:475-483
- Schernathaner G et al. Diabetes Obes Metab 2012; 14:470-478
- Johansen OE, et al Oral presentation. 376-OR. Data presented at the 73rd scientific sessions of the American Diabetes Association. Chicago; IL, USA. June 21–25, 2013
- Januvia (sitagliptin) Summary of Product Characteristics Available at: http://www.medicines.org.uk/emc/medicine/19609/SPC/JANUVIA+25mg%2c+50mg%2c+100mg+film-coated+tablets/ (accessed June 2013)
- Galvus (vildagliptin) Summary of Product Characteristics Available at: http://www.medicines.org.uk/emc/medicine/20734/SPC/Galvus+50+mg+Tablets/ (accessed June 2013)
- Onglyza (saxagliptin) Summary of Product Characteristics Available at: http://www.medicines.org.uk/emc/medicine/22315/SPC/Onglyza+2.5mg+%26+5mg+film-coated+tablets/ (accessed June 2013)
- Vincent SH et al. Drug Metab Dispos 2007;35:533-538
- Food and Drug Administration (FDA) Guidance for Industry Diabetes Mellitus – Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM071627.pdf (accessed June 2013)
- Barnett AH et al. Poster No. 1017-p. The 72nd Scientific Sessions of the American Diabetes Association, 8-12 June 2012, Philadelphia, PA, USA
- Cooper M et al. Poster No.1068-P, The 71st Scientific Sessions of the American Diabetes Association, 24-28 June 2011. San Diago, CA USA
- McGill JB et al. Diabetes Care 2013 36: 237-244
- Yki-Jarvinen H, et al, Oral presentation No.6. The 48th Annual meeting of the European Association for the Study of Diabetes, 1-5 October 2012, Berlin, Germany
- Jentadueto Summary of Product Characteristics. Available at: http://www.medicines.org.uk/emc/medicine/26999/SPC/Jentadueto+2.5+mg+850+mg+film-coated+tablets/ (accessed June 2013)
- Jentadueto Summary of Product Characteristics. Available at: http://www.medicines.org.uk/emc/medicine/27000/SPC/Jentadueto+2.5+mg+1000+mg+film-coated+tablets/ (accessed June 2013)